Evidence map›Paper›PMID 25464924›Full record

ReviewCytokine2015

The dual nature of interleukin-10 in pemphigus vulgaris.

Michael Jeffrey Cho, Christoph T Ellebrecht, Aimee S Payne

Open access · greenAbstract readReview
In one paragraph

Review in Cytokine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. The Immunogenetics of Autoimmune Blistering Diseases.Advances in experimental medicine and biology · 2022
    Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Michael Jeffrey ChoDepartment of Dermatology, University of Pennsylvania, Philadelphia, PA 19104, USA.
Christoph T EllebrechtDepartment of Dermatology, University of Pennsylvania, Philadelphia, PA 19104, USA.
Aimee S PayneDepartment of Dermatology, University of Pennsylvania, Philadelphia, PA 19104, USA. Electronic address: paynea@mail.med.upenn.edu.
University of Pennsylvania · US

Funding

Penn Dermatology Research Training ProgramT32AR007465 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI Elizabeth Anne Grice, David Joel Margolis · 1986 to 2026
$9.0M
Structure and Function of Human Pemphigus AutoantibodiesR56AR064220 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI PAYNE, AIMEE S · 2014 to 2014
$400k
Defining Common Mechanisms of Autoimmunity in Pemphigus VulgarisF31AR066456 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI CHO, MICHAEL TEJADA · 2014 to 2016
$73k
NIAMS NIH HHS AR064220NIAMS NIH HHS F31 AR066456NIAMS NIH HHS R56 AR064220NIAMS NIH HHS T32 AR007465NIAMS NIH HHS T32-AR007465
6 · The paper itself

Abstract

The immunomodulatory cytokine interleukin-10 (IL-10) plays beneficial but also potentially detrimental roles in inflammation, infection, and autoimmunity. Recent studies suggest a regulatory role for IL-10-expressing B cells in the autoimmune blistering disease pemphigus vulgaris. Here we review the studies on IL-10 in pemphigus vulgaris and discuss the potential pathophysiological significance of these findings in comparison to prior studies of IL-10 in other human conditions. A better understanding of the complex roles of IL-10 in immune regulation may improve our understanding of pemphigus pathogenesis and treatment.

Indexed as

AnimalsHomeostasisHumansImmunityInterleukin-10Models, BiologicalPemphigusInterleukin-10AutoimmunityInterleukin-10Pemphigus

Identifiers

PMID25464924
PMCPMC4437817
OpenAlexW2035946094

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.